default author photo

Cécile Tremblay

University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM)

SCHOLARLY PAPERS

4

DOWNLOADS

197

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

On-Demand Hospital-Based SARS-CoV-2 Genomic Epidemiology to Support Nosocomial Outbreak Investigations: A Prospective Molecular Epidemiology Study in Montreal

Number of pages: 31 Posted: 29 Aug 2022
University of Montreal - Department of Microbiology, Infectious Diseases and Immunology, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Immunopathology Axis, University of Montreal - Infection Prevention and Control Service, University of Montreal - Infection Prevention and Control Service, University of Montreal - Infectious Diseases Service, University of Montreal - Molecular Biology Service, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Department of Microbiology, Infectious Diseases and Immunology, University of British Columbia (UBC) - Department of Medicine, University of Montreal - Department of Microbiology, Infectious Diseases and Immunology, University of Montreal - Department of Biochemistry and Molecular Medicine, University of Montreal - Department of Microbiology, Infectious Diseases and Immunology and University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM)
Downloads 130 (558,171)

Abstract:

Loading...

COVID, Infection Control, Molecular epidemiology, Hospital epidemiology, Genomics

2.

Temporal Associations of B and T Cell Immunity with Robust Vaccine Responsiveness in a 16-Week Interval BNT162B2 Regimen

Number of pages: 53 Posted: 03 Feb 2022
University of Montreal, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), affiliation not provided to SSRN, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Centre de Recherche du CHUM, affiliation not provided to SSRN, McGill University, Centre de Recherche du CHUM, University of Montreal, University of Montreal - Department of Microbiology, Infectious Diseases and Immunology, Centre de Recherche du CHUM, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Centre de Recherche du CHUM, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Centre de Recherche du CHUM and University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM)
Downloads 38 (1,209,354)

Abstract:

Loading...

Coronavirus, COVID-19, SARS-CoV-2, Spike glycoproteins, Longer interval mRNA vaccine regimen, CD4 T cell, CD8 T cell, CD4 T cell help, B cells, humoral responses, AIM assay, immunological memory

3.

A Long Interval Between Priming and Boosting SARS-CoV-2 mRNA Vaccine Doses Enhances B Cell Responses With Limited Impact on T Cell Immunity

Number of pages: 44 Posted: 12 Aug 2022
University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Pennsylvania - Institute for Immunology, University of Pennsylvania - Institute for Immunology, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Pennsylvania - Department of Systems Pharmacology and Translational Therapeutics, University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Centre de Recherche du CHUM, University of Pennsylvania - Institute for Immunology, University of Pennsylvania - Institute for Immunology and University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM)
Downloads 29 (1,332,057)

Abstract:

Loading...

SARS-CoV-2, mRNA vaccine, dose interval, B cells, CD4+ T cells, CD8+ T cells, phenotype

4.

Population-Level Effectiveness of Pre-Exposure Prophylaxis for HIV Prevention Among Men Who Have Sex with Men in Montréal, Canada: A Modelling Study Using Surveillance and Survey Data

9TH INTERNATIONAL CONFERENCE ON INFECTIOUS DISEASE DYNAMICS:O8.1
Posted: 05 Dec 2023
University of Montreal - Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), McGill University, Imperial College London - Department of Infectious Disease Epidemiology, McGill University, McGill University, Simon Fraser University (SFU), McGill University - Epidemiology, Biostatistics, & Occupational Health, McGill University, Clinique médicale l’Actuel, McGill University, Simon Fraser University (SFU), McGill University, McGill University, McGill University - Epidemiology, Biostatistics, & Occupational Health, McGill University and McGill University

Abstract:

Loading...